Events

Medicon Valley Alliance and Kvantify would like to welcome you to a Good Morning Meeting 26th of September 2024. Our upcoming presentation will explore the transformative role of computational methods in drug discovery, which save time, conserve resources, and enhance efficiency in drug discovery pipelines. We’ll demonstrate how novel physics-based methods, rooted in physical principles, […]

Medicon Valley Alliance and Menarini Biotech would like to welcome you to a Good Morning Meeting 25 th of September 2024. Menarini Biotech brings over 20 years of expertise in antibody and bioconjugation drug substance development, formulation, and drug product manufacturing to biotech companies everywhere. If you’re working with antibodies and looking to accelerate your […]

Medicon Valley Alliance and GemPharmatech would like to welcome you to a Good Morning Meeting 24th of September 2024. In the fast-paced world of drug development, timing is everything, and the expertise of your research partner can make or break your project. Join us for an exclusive event designed to help you master the art […]

Join us with your morning coffee at the Medicon Village Innovation booth (A17) on 19 September from 9:00 to 10:00 during the Nordic Life Science Days 2024 in Malmö. Meet HALRIC Ambassadors and Industry Outreach advisors to find out how you can get access to our cross-border network! And how HALRIC can be a shortcut […]

Medicon Valley Alliance would like to welcome you to this MedTech Network Meeting on the 17th of September 2024. This meeting features presentations from five companies at various stages of their development. Each speaker will share their company’s journey, focusing on key strategies, innovations, and experiences that have led to their current success. Topics will […]

Medicon Valley Alliance and IQVIA would like to welcome you to a Good Morning Meeting 5th of September 2024. Real world evidence (RWE) is becoming increasingly important throughout the product lifecycle. Once considered optional, it is now a necessity. With increasing focus from both regulatory and market access stakeholders, RWE requirements need to be planned […]

This event is a platform based on the concept of synergies between science and business. Meet R&D people and pharma industry representatives. Increase your awareness and gain more knowledge about this exciting topic. The seminar programme will revolve around advancements in formulations and cutting-edge technologies that can allow cheaper, safer and more effective drugs. Pharmaceutical […]

CEO Anette Steenberg and Vice-Chair of MVA Ulf Andersson, CEO of Medeon Life Science Incubator Park will be attending Almedalen. If you wish to engage with us please reach out! Anette Steenberg CEO as@mva.org Ulf G. Andersson Vice Chairman of the Board ulf.g.andersson@medeon.se  

Representatives from MVA will be attending Folkemødet on Bornholm. You are welcome to reach out to us for engagement – on stage or bilaterally. Anette Steenberg CEO, as@mva.org, +45 60 87 21 02 David Munis Zepernick Director Member Engagements and Communication, dz@mva.org, +45 24 98 16 68 Mette Bach Dyremose Head of Communication & Industry […]

Medicon Valley Alliance and Quotient Sciences would like to welcome you to a Good Morning Meeting. In this presentation, Dr. Andrew Parker will discuss transitioning from pre-clinical to clinical stages, covering regulatory expectations and enabling technologies for poorly soluble molecules. He will also showcase solutions developed by our team using the Quotient Sciences Translational Pharmaceutics® […]

Medicon Valley Alliance and PharmaLex are pleased to invite you to a Good Morning Meeting on the 11th of June in Copenhagen focusing on How to help being compliant with EU GMP Annex 1 – A practical perspective. The EU GMP Annex 1 “Manufacture of Sterile Medicinal Products” came into effect as of August 2023, […]

Type 1 diabetes is one of the most prevalent chronic diseases. The disease places a lifelong burden on the patient and the immediate family and triggers significant societal costs. Through the early detection of people at risk of type 1 diabetes, there is a prospect that new drugs can delay, and in the long term […]

Medicon Valley Alliance and PharmaLex are pleased to invite you to a Good Morning Meeting on the 7th of June in Copenhagen. Clinically developing targeted therapies is considered a complex and time-consuming process, requiring a deep understanding of disease biology and the molecular mechanisms driving disease. But the complexities go far beyond the science. Targeted […]

Medicon Valley Alliance and BioAgilytix would like to welcome you to a Good Morning Meeting. In the realm of biotherapeutics, which include a diverse array of antibodies, proteins, hormones, enzymes and peptides, understanding and managing immunogenicity is of paramount importance. As biotherapeutic modalities increase in complexity, so too does the immunogenicity assessment strategy and the […]

This international educational forum has an emphasis on new directions, R&D and improvements of biologics, bioprocessing and ATMP with a focus on technical, rather than commercial, achievements. Topics may include analytical techniques, cell culturing and upstream processing, downstream processing, single-use systems, gene-therapy and regulatory issues. The event is mainly aimed at the following target audience: […]

During the last two decades, the gut microbiome has emerged as an important contributor to human health and a new generation of solutions targeted the gut has started to emerge. Reflecting on the challenges faced a decade or more ago, wherein scientists and companies struggled to provide sufficient scientific evidence for their probiotic products to […]

Medicon Valley Alliance and Greenlight Guru are pleased to invite you to this Full Day Conference on the 16th of May in Copenhagen. Greenlight Guru’s mission is to improve the quality of life by helping device makers imagine, introduce and advance higher quality devices faster, with less risk. Since the very beginning, we’ve been dedicated […]

This event brings together leading experts to discuss the current landscape, challenges, and innovative developments in the field. From a detailed overview of lung cancer types and existing treatments to insights into immune-oncology (IO) advancements, small molecules, antibody-drug conjugates (ADCs), and biomarkers, this gathering will be a comprehensive exploration of the complexities in lung cancer […]

Medicon Valley Alliance is happy to extend an invitation to all MVA Executive Club members to MVA Executive Club Dinner Meeting, which once again takes place at Clarion Hotel Copenhagen Airport on the 8th of May 2024. Join us for networking with both new and familiar faces and be inspired by Dagbladet Børsen’s CEO and […]

Hologic and Medicon Valley Alliance invite you to join this meeting focusing on women’s health in the Nordics. How can we tackle gender biases in medical education and research to develop a gender-based, personalized women’s healthcare? How can AI and advanced imaging techniques contribute to the early detection of breast cancers that risk being missed […]

Medicon Valley Alliance and Celerion would like to welcome you to a Good Morning Meeting. Abstract: Transitioning an experimental drug from preclinical animal models to the clinic is a critical milestone in bringing new medications to the market. First-in-Human (FiH) clinical studies have undergone a significant evolution, from a basic “feed-and-bleed” model in the 1970s, […]

The General Assembly is held as a hybrid event, where you can participate both physically or online. If you have colleagues who would like to participate, please feel free to share the link. Please note that your company only has 1 vote when votes are counted. If your company cannot participate, you have the option […]

Nanomedicine is defined as nanotechnology embedded in medical applications ultimately for diagnosing and/or treatment of patients. Nanotechnology is a cutting-edge advancement within science and engineering. It is not a single field but an intense collaboration between disciplines to manipulate materials on the atomic and molecular level. When this technology is applied to medicine, the results […]

In the dynamic landscape of microbiome research and development, the journey from concept to market success is often complex and multifaceted. This meeting aims to provide valuable insights and strategies for navigating this pathway successfully. The successful translation of innovative microbiome-based solutions into tangible products holds significant potential for positively impacting healthcare. Whether you are […]

The manufacturer´s focus during the medical device life-cycle is to continuously ensure safety and performance of the device, this is done by iterating/ updating the technical documents such as the clinical evaluation and risk management regularly and when triggered. Collecting clinical data by investigations is time consuming and costly. Market access is not only dependent […]